BackAvidity Biosciences Overview
Avidity Biosciences Inc

Avidity Biosciences Target Price

See Avidity Biosciences's analyst price targets ($25) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$9.5

Average Target Price

$25.00163.2% upside

2 analysts in the last 4 months

High: $25 | Low: $25

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-06H.C. Wainwright$25163.2% upsideOpen
2026-06-18Cantor Fitzgerald$25163.2% upsideOpen
2026-05-15Leerink Partners$25163.2% upsideOpen

Avidity Biosciences (RNA) FAQ

As of the most recent data, RNA shows a target price of $25. Scroll down for historical charts and peer comparison views.

If Avidity Biosciences moved to the average analyst target of $25, shares would be roughly 163.2% higher than $9.5. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Avidity Biosciences's earnings trajectory.

Besides this target price page, Stockcircle has Avidity Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $25) with ownership activity and broader fundamentals.

Avidity Biosciences's target price is $25; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.